Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Take advantage of free courses on financial planning for beginners to boost your financial knowledge. Start your learning journey today.
10,761 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Rayse introduces RAE, a conversational AI engine that lets agents log work and guide client journeys via voice or tex...
Visa sits at the center of a rising wave of short bets, even as it preserves a cash-generating moat. The latest data ...
February 2025 reshapes the field for the best high-yield savings accounts as rate signals and competition push new pr...
Micron stock has jumped this year but pulled back in early 2026. Analysts say the AI memory demand cycle could push M...
A new breed of data firms is staking its future on owning compute. This land data startup is buying GPUs and mapping ...
Investors often wonder where will Realty Income head in ten years. This article breaks down how its net-lease model, ...
When OppFi shares their Q4 2025 earnings, investors want clarity on profitability, credit quality, and growth. This g...
Oil prices rose as the IEA deployed an historic stock draw, yet Carlyle Group’s Currie argued there’s policy response...
Uber expands its autonomous-vehicle ambitions by teaming up with Zoox, clouding the landscape with more AV partners a...
A large institutional stake in Enviri sparks questions about the company’s trajectory. This article breaks down what ...
Remitly, a digital remittance pioneer, posted strong revenue growth while an institutional investor made a sizable mo...